Bosh sahifaDMYD-B • STO
add
Diamyd Medical AB
Yopilish kursi
17,30 kr
Kunlik diapazon
16,68 kr - 17,88 kr
Yillik diapazon
7,50 kr - 17,88 kr
Bozor kapitalizatsiyasi
2,36 mlrd SEK
Oʻrtacha hajm
598,91 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
STO
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (SEK) | noy, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 245,00 ming | 842,31% |
Joriy xarajat | 48,14 mln | 15,02% |
Sof foyda | -48,84 mln | -35,07% |
Sof foyda marjasi | -19,94 ming | 85,67% |
Har bir ulushga tushum | — | — |
EBITDA | -47,06 mln | -13,67% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (SEK) | noy, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 233,18 mln | 52,53% |
Jami aktivlari | 302,46 mln | 35,70% |
Jami passivlari | 70,82 mln | 6,05% |
Umumiy kapital | 231,64 mln | — |
Tarqatilgan aksiyalar | 137,50 mln | — |
Narxi/balansdagi bahosi | 10,30 | — |
Aktivlardan daromad | -37,27% | — |
Kapitaldan daromad | -47,73% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (SEK) | noy, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -48,84 mln | -35,07% |
Operatsiyalardan naqd pul | -43,70 mln | -4,49% |
Sarmoyadan naqd pul | -20,10 mln | -183,55% |
Moliyadan naqd pul | 7,00 ming | -99,99% |
Naqd pulning sof oʻzgarishi | -63,85 mln | -259,15% |
Boʻsh pul | -27,48 mln | 11,67% |
Haqida
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
41
